Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.29M | 54.62M | 51.05M | 38.01M | 38.19M |
| Total Depreciation and Amortization | 23.73M | -13.66M | 24.17M | 24.71M | 24.34M |
| Total Amortization of Deferred Charges | -- | 37.80M | -- | -- | -- |
| Total Other Non-Cash Items | 14.19M | 12.84M | 15.57M | 17.84M | 7.91M |
| Change in Net Operating Assets | 6.90M | 3.81M | -4.12M | 1.85M | -42.85M |
| Cash from Operations | 73.11M | 95.42M | 86.66M | 82.41M | 27.59M |
| Capital Expenditure | -5.92M | -8.48M | -9.09M | -5.92M | -5.36M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 4.62M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.99M | 1.42M | 3.27M | 0.00 | 1.35M |
| Cash from Investing | -3.93M | -7.06M | -5.82M | -5.92M | 605.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -60.00M | -40.00M | -46.00M |
| Issuance of Common Stock | 36.18M | 22.43M | 29.96M | 4.74M | 23.50M |
| Repurchase of Common Stock | -7.24M | -43.15M | -157.00K | -1.26M | -9.26M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -12.56M | -12.48M | -12.52M | -12.47M | -12.44M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.39M | -33.21M | -42.72M | -48.99M | -44.20M |
| Foreign Exchange rate Adjustments | -247.00K | -258.00K | -1.19M | 413.00K | -1.21M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.32M | 54.89M | 36.94M | 27.92M | -17.22M |